Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.
- DOI
- 10.1016/j.jaad.2026.05.048
- Published
- 2026 Oct
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.05.048,
title = {Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.},
author = {Soung J and Cui Y and Bissonnette R and Lebwohl MG and González-Cantero Á and Pinter A and Rich P and Prajapati VH and Miller-Kassamali M and Cafone J and Jiang J and Li S and Yang YW and Pink AE},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.05.048},
url = {https://doi.org/10.1016/j.jaad.2026.05.048}
}RIS
TY - JOUR TI - Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study. AU - Soung J AU - Cui Y AU - Bissonnette R AU - Lebwohl MG AU - González-Cantero Á AU - Pinter A AU - Rich P AU - Prajapati VH AU - Miller-Kassamali M AU - Cafone J AU - Jiang J AU - Li S AU - Yang YW AU - Pink AE PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.05.048 UR - https://doi.org/10.1016/j.jaad.2026.05.048 ER -
APA
J, S., Y, C., R, B., MG, L., Á, G., A, P., P, R., VH, P., M, M., J, C., J, J., S, L., YW, Y., & AE, P. (2026). Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.05.048
Source records
- pubmed · retrieved 2026-09-26T15:53:21.872Z